| Literature DB >> 35235844 |
Mary Shank-Retzlaff1, Yolanda Peris Taverner2, Pallavi Joshi2, Sankar Renu2, Arun Chitikela2, Animesh Koneru2, Zhuoran Wang2, Laura Bronsart2, Pravansu Mohanty2.
Abstract
Capillary-mediated vitrification (CMV) is a novel method for stabilizing biological molecules and complexes. CMV leverages capillary evaporation to enable rapid desiccation of aqueous solutions while avoiding both freezing and boiling. In the CMV process, an aqueous solution containing the biological material of interest and common excipients is applied to a solid, porous support, referred to as the scaffold, and desiccated under vacuum. The pores within the scaffold accelerate drying by increasing surface area while preventing boiling through the interaction of the vapor pressure, capillary forces, and viscous forces. The process, which can be completed in under an hour, produces an amorphous dried product with enhanced thermal stability. In this study, CMV is demonstrated using luciferase as a model system. Using a 30-minute drying time, residual moisture levels of <4% were achieved. CMV-stabilized luciferase maintained full activity when stored for up to 6 weeks at 25 °C and >70% activity after 6 weeks at temperatures up to 45 °C. The liquid formulated enzyme lost all activity after 1 day at 37 °C or 4 h at temperatures above 37 °C. The data presented in this report demonstrate that CMV is a promising alternative to traditional biopreservation methods.Entities:
Keywords: Drug delivery system; Enzymes; Global health; Lyophilization; Macromolecular drug delivery; Proteins; Stability
Mesh:
Substances:
Year: 2022 PMID: 35235844 DOI: 10.1016/j.xphs.2022.02.015
Source DB: PubMed Journal: J Pharm Sci ISSN: 0022-3549 Impact factor: 3.784